Education
About Us
Working with TipRanks
Follow Us
Caley Castelein Insider Profile
11 Followers
Caley Castelein, Director at Viewray, holds 0.00 shares in Tourmaline Bio (Ticker: TRML), holds 2.19M shares in Whitehawk Therapeutics (Ticker: WHWK), holds 99.05K shares in Viewray (Ticker: VRAYQ).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+4.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Caley Castelein holds in companies
Most Profitable Insider Trade
Stock:
Tourmaline Bio
(TRML)
(TRML)
Rating:Informative Buy
Date:Oct 27, 2023 - Oct 27, 2024
Return:+89.90%
The most profitable trade made by Caley Castelein
Caley Castelein's Trading History
Viewray
Jul 21, 2023
Director
Informative Sell
162.57K
―
Whitehawk Therapeutics
Mar 04, 2025
Director
Uninformative Buy
4.00M
$7.08M
Tourmaline Bio
Oct 28, 2025
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Caley Castelein's performance on stock
You May Also Like
Caley Castelein insider profile FAQ
What is the percentage of profitable transactions made by Caley Castelein?
The percentage of profitable transactions made by Caley Castelein is 50%.
What is the average return per transaction made by Caley Castelein?
The average return per transaction made by Caley Castelein is 4.70%.
What stocks does Caley Castelein hold?
Caley Castelein holds: VRAYQ, WHWK, TRML stocks.
What was Caley Castelein’s latest transaction?
Caley Castelein latest transaction was an Uninformative Sell of ―.
What was Caley Castelein's most profitable transaction?
Caley Castelein’s most profitable transaction was an Informative Buy of TRML stock on October 27, 2023. The return on the trade was 89.90%.
What is Caley Castelein's role in Viewray?
Caley Castelein's role in Viewray is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.